Business Wire

Predicta Biosciences Secures $5.2M to Transform the Diagnosis, Treatment and Monitoring of Blood Cancers

BOSTON--(BUSINESS WIRE)--Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced it has raised an oversubscribed $5.2 million seed ...
Nasdaq

Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers and Autoimmune Diseases

Brian McKernan joins as CEO to further advance Predicta’s clinical impact, including its non-invasive diagnostic for Multiple Myeloma “It’s an honor to join Predicta and our strong team of leading ...
Business Wire

Predicta’s AI Offers Tips for EV Reviewers Based on EV Owner Topic Data

DALLAS--(BUSINESS WIRE)--Predicta (www.predicta.com/blog) used AI to evaluate differences in professional EV reviews and the lived EV experience according to owners ...
The Next Web

Brazil’s Predicta expands into the US, using site optimization platform SiteApps as flagship

Predicta is expanding to the US and opening offices in Silicon Valley, the decade-old Brazilian B2B tech company announced today. As you may remember, it first announced these plans last December in ...
The Next Web

One of Brazil’s most innovative tech firms is finally expanding to Silicon Valley, here’s why

The Brazilian media group Grupo RBS has taken a minority share in Predicta, the companies announced today. As we reported, Predicta is one of Brazil’s most innovative companies. With a staff of 130 ...